Cytochalasin B-induced membrane vesicles convey angiogenic activity of parental cells

Marina O. Gomzikova; Margarita N. Zhuravleva; Regina R. Miftakhova; Svetlana S. Arkhipova; Vladimir G. Evtugin; Svetlana F. Khaiboullina; Andrey P. Kiyasov; Jenny L. Persson; Nigel P. Mongan; Richard G. Pestell; Albert A. Rizvanov

doi:10.18632/oncotarget.19723

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Cytochalasin B-induced membrane vesicles convey angiogenic activity of parental cells

Marina O. Gomzikova, Margarita N. Zhuravleva, Regina R. Miftakhova, Svetlana S. Arkhipova, Vladimir G. Evtugin, Svetlana F. Khaiboullina, Andrey P. Kiyasov, Jenny L. Persson, Nigel P. Mongan, Richard G. Pestell and Albert A. Rizvanov _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2017; 8:70496-70507. https://doi.org/10.18632/oncotarget.19723

Metrics: PDF 2767 views | HTML 7020 views | ?

Abstract

Marina O. Gomzikova1, Margarita N. Zhuravleva1, Regina R. Miftakhova1, Svetlana S. Arkhipova1, Vladimir G. Evtugin1, Svetlana F. Khaiboullina1,2, Andrey P. Kiyasov1, Jenny L. Persson3,4, Nigel P. Mongan5,6, Richard G. Pestell7,8 and Albert A. Rizvanov1

1Kazan Federal University, Kazan 420008, Russia

2Department of Microbiology and Immunology, University of Nevada, Reno, NV 89557, USA

3Department of Translational Medicine, Lund University, Malmö 205 02, Sweden

4Department of Molecular Biology, Umeö University, Umeö 901 87, Sweden

5Cancer Biology and Translational Research, School of Veterinary Medicine and Science, University of Nottingham, Nottingham LE12 5RD, UK

6Department of Pharmacology, Weill Cornell Medicine, New York, NY 10065, USA

7Pennsylvania Cancer and Regenerative Medicine Research Center, Baruch S. Blumberg Institute, Pennsylvania Biotechnology Center, Wynnewood, PA 19096, USA

8Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 637551, Singapore

Correspondence to:

Albert A. Rizvanov, email: [email protected]

Keywords: extracellular vesicles, membrane vesicles, cytochalasin B-induced membrane vesicles, angiogenesis, cell-free therapy

Received: March 15, 2017 Accepted: June 17, 2017 Published: July 31, 2017

ABSTRACT

Naturally occurring extracellular vesicles (EVs) play essential roles in intracellular communication and delivery of bioactive molecules. Therefore it has been suggested that EVs could be used for delivery of therapeutics. However, to date the therapeutic application of EVs has been limited by number of factors, including limited yield and full understanding of their biological activities. To address these issues, we analyzed the morphology, molecular composition, fusion capacity and biological activity of Cytochalasin B-induced membrane vesicles (CIMVs). The size of these vesicles was comparable to that of naturally occurring EVs. In addition, we have shown that CIMVs from human SH-SY5Y cells contain elevated levels of VEGF as compared to the parental cells, and stimulate angiogenesis in vitro and in vivo.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 19723

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Papers:

Cytochalasin B-induced membrane vesicles convey angiogenic activity of parental cells

Abstract